Latest News in the pharma Industry

Research & Development

FDA grants Priority Review to Genentech's emicizumab for Hemophilia A with inhibitors

FDA grants Priority Review to Genentech's emicizumab for Hemophilia A with inhibitors

24 Aug 2017

Application based on positive results of Phase III study in adults and adolescents with hemophilia A with inhibitors and interim Phase III results in children.

Read more 
Novavax’ preclinical influenza nanoparticle study published in Vaccine

Novavax’ preclinical influenza nanoparticle study published in Vaccine

23 Aug 2017

Data suggest that NanoFlu has the potential to elicit a broader, more robust immune response, resulting in greater protection than the market-leading licensed influenza vaccine in older adults.

Read more 
Novartis and MMV launch patient trial in Africa for a novel compound against multidrug-resistant malaria

Novartis and MMV launch patient trial in Africa for a novel compound against multidrug-resistant malaria

23 Aug 2017

Compound has potential to be a game-changer in malaria elimination, rapidly clearing malaria infection, including resistant strains, and blocking parasite transmission.

Read more 
Champions Oncology collaborates with AstraZeneca to develop unique cohorts of PDX models

Champions Oncology collaborates with AstraZeneca to develop unique cohorts of PDX models

21 Aug 2017

Models will be used in AstraZeneca's oncology R&D programs in breast and lung cancer.

Read more 
BMS and Pfizer to highlight commitment to reducing the risk of stroke at ECS Congress 2017

BMS and Pfizer to highlight commitment to reducing the risk of stroke at ECS Congress 2017

20 Aug 2017

Eliquis clinical data include results from a Phase IV trial to be featured in late-breaking science sessions,

Read more 
A plant-based delivery system for anti-cancer drugs

A plant-based delivery system for anti-cancer drugs

20 Aug 2017

Study demonstrates that a complex consisting of tobacco mosaic virus and vcMMAE can kill cancer cells.

Read more 
Metacrine collaborates on development of FGF1 variants for glucose lowering and improving insulin sensitivity

Metacrine collaborates on development of FGF1 variants for glucose lowering and improving insulin sensitivity

16 Aug 2017

Novo Nordisk will have an option to license the FGF1 program upon achievement of certain research milestones.

Read more 
Regeneron to discontinue development of suptavumab for respiratory syncytial virus

Regeneron to discontinue development of suptavumab for respiratory syncytial virus

14 Aug 2017

Phase III study fails to meet its primary endpoint.

Read more 
Ionis to go it alone with Inotersen and IONIS-FB-L Rx after GSK decline

Ionis to go it alone with Inotersen and IONIS-FB-L Rx after GSK decline

14 Aug 2017

Inotersen on track for marketing authorization filings this year.

Read more 
Fortress Biotech forms new subsidiary, Aevitas Therapeutics

Fortress Biotech forms new subsidiary, Aevitas Therapeutics

14 Aug 2017

Subsidiary to develop novel AAV gene therapy treatments for complement-mediated.

Read more 
Kalytera submits Phase II study protocol to IRBs for cannabidiol in the prevention of GvHD

Kalytera submits Phase II study protocol to IRBs for cannabidiol in the prevention of GvHD

14 Aug 2017

The Phase II study is designed to generate the pharmacokinetic and safety data, at multiple dose levels, that will be required by the FDA.

Read more 
FDA removes clinical hold on CEL-SCI’s Phase III head & neck cancer trial

FDA removes clinical hold on CEL-SCI’s Phase III head & neck cancer trial

14 Aug 2017

The last FDA approved treatment for advanced primary head and neck cancer was over 50 years ago.

Read more